255 related articles for article (PubMed ID: 32007537)
1. Risk of Metachronous Colorectal Neoplasm after a Segmental Colectomy in Lynch Syndrome Patients According to Mismatch Repair Gene Status.
Quezada-Diaz FF; Hameed I; von Mueffling A; Salo-Mullen EE; Catalano A; Smith JJ; Weiser MR; Garcia-Aguilar J; Stadler ZK; Guillem JG
J Am Coll Surg; 2020 Apr; 230(4):669-675. PubMed ID: 32007537
[TBL] [Abstract][Full Text] [Related]
2. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.
Parry S; Win AK; Parry B; Macrae FA; Gurrin LC; Church JM; Baron JA; Giles GG; Leggett BA; Winship I; Lipton L; Young GP; Young JP; Lodge CJ; Southey MC; Newcomb PA; Le Marchand L; Haile RW; Lindor NM; Gallinger S; Hopper JL; Jenkins MA
Gut; 2011 Jul; 60(7):950-7. PubMed ID: 21193451
[TBL] [Abstract][Full Text] [Related]
3. Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.
Kim TJ; Kim ER; Hong SN; Kim YH; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Kim K; Kim K; Chang DK
Ann Surg Oncol; 2017 Apr; 24(4):1085-1092. PubMed ID: 27766559
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
[TBL] [Abstract][Full Text] [Related]
5. Associations Between Mutations in MSH6 and PMS2 and Risk of Surveillance-detected Colorectal Cancer.
Lamba M; Wakeman C; Ebel R; Hamilton S; Frampton C; Kiesanowski M; Griffiths B; Keating J; Parry S; Chalmers-Watson T
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2768-2774. PubMed ID: 32240831
[TBL] [Abstract][Full Text] [Related]
6. Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
Buchanan DD; Clendenning M; Rosty C; Eriksen SV; Walsh MD; Walters RJ; Thibodeau SN; Stewart J; Preston S; Win AK; Flander L; Ouakrim DA; Macrae FA; Boussioutas A; Winship IM; Giles GG; Hopper JL; Southey MC; English D; Jenkins MA
J Gastroenterol Hepatol; 2017 Feb; 32(2):427-438. PubMed ID: 27273229
[TBL] [Abstract][Full Text] [Related]
7. Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.
Vyas M; Firat C; Hechtman JF; Weiser MR; Yaeger R; Vanderbilt C; Benhamida JK; Keshinro A; Zhang L; Ntiamoah P; Gonzalez M; Andrade R; El Dika I; Markowitz AJ; Smith JJ; Garcia-Aguilar J; Vakiani E; Klimstra DS; Stadler ZK; Shia J
Fam Cancer; 2021 Jul; 20(3):201-213. PubMed ID: 33033905
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of Segmental Colectomy Followed by Endoscopic Surveillance as a Treatment Strategy for Colorectal Cancer Patients with Lynch Syndrome.
Nagasaki T; Arai M; Chino A; Akiyoshi T; Fukunaga Y; Ueno M
Dig Surg; 2018; 35(5):448-456. PubMed ID: 29017165
[TBL] [Abstract][Full Text] [Related]
9. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers.
Win AK; Parry S; Parry B; Kalady MF; Macrae FA; Ahnen DJ; Young GP; Lipton L; Winship I; Boussioutas A; Young JP; Buchanan DD; Arnold J; Le Marchand L; Newcomb PA; Haile RW; Lindor NM; Gallinger S; Hopper JL; Jenkins MA
Ann Surg Oncol; 2013 Jun; 20(6):1829-36. PubMed ID: 23358792
[TBL] [Abstract][Full Text] [Related]
10. The coding microsatellite mutation profile of PMS2-deficient colorectal cancer.
Bajwa-Ten Broeke SW; Ballhausen A; Ahadova A; Suerink M; Bohaumilitzky L; Seidler F; Morreau H; van Wezel T; Krzykalla J; Benner A; de Miranda NF; von Knebel Doeberitz M; Nielsen M; Kloor M
Exp Mol Pathol; 2021 Oct; 122():104668. PubMed ID: 34302852
[TBL] [Abstract][Full Text] [Related]
11. Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study.
Eikenboom EL; Moen S; van Leerdam ME; Papageorgiou G; Doukas M; Tanis PJ; Dekker E; Wagner A; Spaander MCW;
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1106-1117. PubMed ID: 37865103
[TBL] [Abstract][Full Text] [Related]
12. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.
Messick CA; Kravochuck S; Church JM; Kalady MF
Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944
[TBL] [Abstract][Full Text] [Related]
13. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.
Kaur G; Masoud A; Raihan N; Radzi M; Khamizar W; Kam LS
Indian J Med Res; 2011 Aug; 134(2):186-92. PubMed ID: 21911971
[TBL] [Abstract][Full Text] [Related]
14. Subtotal Colectomy for Colon Cancer Reduces the Need for Subsequent Surgery in Lynch Syndrome.
Renkonen-Sinisalo L; Seppälä TT; Järvinen HJ; Mecklin JP
Dis Colon Rectum; 2017 Aug; 60(8):792-799. PubMed ID: 28682964
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
[TBL] [Abstract][Full Text] [Related]
16. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H
J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183
[TBL] [Abstract][Full Text] [Related]
17. Yield of Lynch Syndrome Surveillance for Patients With Pathogenic Variants in DNA Mismatch Repair Genes.
Goverde A; Eikenboom EL; Viskil EL; Bruno MJ; Doukas M; Dinjens WNM; Dubbink EJ; van den Ouweland AMW; Hofstra RMW; Wagner A; Spaander MCW
Clin Gastroenterol Hepatol; 2020 May; 18(5):1112-1120.e1. PubMed ID: 31470178
[TBL] [Abstract][Full Text] [Related]
18. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome.
Ranganathan M; Sacca RE; Trottier M; Maio A; Kemel Y; Salo-Mullen E; Catchings A; Kane S; Wang C; Ravichandran V; Ptashkin R; Mehta N; Garcia-Aguilar J; Weiser MR; Donoghue MTA; Berger MF; Mandelker D; Walsh MF; Carlo M; Liu YL; Cercek A; Yaeger R; Saltz L; Segal NH; Mendelsohn RB; Markowitz AJ; Offit K; Shia J; Stadler ZK; Latham A
JCO Precis Oncol; 2023 May; 7():e2200675. PubMed ID: 37262391
[TBL] [Abstract][Full Text] [Related]
20. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]